IRD

Opus Genetics, Inc. Common Stock
IRD

Overview Fund Activity

27 hedge funds and large institutions have $3.19M invested in Opus Genetics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
4
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
-$7K

Top Buyers

1
TSS
1
Two Sigma Securities
New York
$24K
2
ARTA
2
A.R.T. Advisors
New York
$20K
3
UBS Group
3
UBS Group
Switzerland
$13K
4
BlackRock
4
BlackRock
New York
$344K
5
Bank of America
5
Bank of America
North Carolina
$2K

Top Sellers

1
VF
1
Virtu Financial
New York
$94K
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
NFC
3
Northeast Financial Consultants
Connecticut
$0
4
Jane Street
4
Jane Street
New York
$0
5
LTFS
5
Ladenburg Thalmann Financial Services
Florida
$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
NFC
26
Northeast Financial Consultants
Connecticut
– -$21K -313 Closed
Jane Street
27
Jane Street
New York
– -$19K -276 Closed
1
2